about
The G-308A variant of the Tumor Necrosis Factor-alpha (TNF-alpha) gene is not associated with obesity, insulin resistance and body fat distributionHypovitaminosis D is independently associated with metabolic syndrome in obese patients.Search for genetic variants in the p66Shc longevity gene by PCR-single strand conformational polymorphism in patients with early-onset cardiovascular disease.Effects of metformin and exercise training, alone or in association, on cardio-pulmonary performance and quality of life in insulin resistance patientsRelationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.Prevalence of type 1 diabetes autoantibodies (GADA, IA2, and IAA) in overweight and obese childrenStrong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes.The common PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity.Altered glucose homeostasis is associated with increased serum apelin levels in type 2 diabetes mellitus.Glycated hemoglobin for the diagnosis of diabetes and prediabetes: Diagnostic impact on obese and lean subjects, and phenotypic characterization.Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans.Comparison of non-HDL-cholesterol versus triglycerides-to-HDL-cholesterol ratio in relation to cardiometabolic risk factors and preclinical organ damage in overweight/obese children: the CARITALY study.Association of FTO polymorphisms with early age of obesity in obese Italian subjectsNo effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.Effects of Metformin and Exercise Training, Alone or in Combination, on Cardiac Function in Individuals with Insulin Resistance.The COBLL1 C allele is associated with lower serum insulin levels and lower insulin resistance in overweight and obese childrenAssociation of RXR-Gamma Gene Variants with Familial Combined Hyperlipidemia: Genotype and Haplotype Analysis.Childhood obesity classification systems and cardiometabolic risk factors: a comparison of the Italian, World Health Organization and International Obesity Task Force references.Unravelling the pathogenesis of fatty liver disease: patatin-like phospholipase domain-containing 3 protein.High normal post-load plasma glucose, cardiometabolic risk factors and signs of organ damage in obese children.Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly.Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly.The vitamin D receptor functional variant rs2228570 (C>T) does not associate with type 2 diabetes mellitus.Anterior pituitary autoantibodies in patients with type 1 diabetes mellitus: methodological problems and clinical correlations.The IRS1 rs2943641 variant and risk of future cancer among morbidly obese individuals.A new index to simplify the screening of hypertension in overweight or obese youth.White blood cell count may identify abnormal cardiometabolic phenotype and preclinical organ damage in overweight/obese children.Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study)The "Sapienza University Mortality and Morbidity Event Rate (SUMMER) study in diabetes": Study protocol.Genetic variation around the collagen IV 1a gene locus and proliferative retinopathy in type 2 diabetes mellitus.Affected sib-pair analysis of the GLUT1 glucose transporter gene locus in non-insulin-dependent diabetes mellitus (NIDDM): evidence for no linkage.The Arg282Ser missense mutation in APOA5 gene determines a reduction of triglyceride and LDL-cholesterol in children, together with low serum levels of apolipoprotein A-V.MODY-like diabetes associated with an apparently balanced translocation: possible involvement of MPP7 gene and cell polarity in the pathogenesis of diabetes.Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study).Severe hypoglycemia in patients with known diabetes requiring emergency department care: A report from an Italian multicenter study.The G972R variant of the insulin receptor substrate-1 gene impairs insulin signaling and cell differentiation in 3T3L1 adipocytes; treatment with a PPARgamma agonist restores normal cell signaling and differentiation.Analysis of TBC1D4 in patients with severe insulin resistance.Clinical application of best practice guidelines for the genetic diagnosis of MODY2 and MODY3.The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life.The G972R variant of the insulin receptor substrate-1 (IRS-1) gene, body fat distribution and insulin-resistance.
P50
Q24804687-A0D50538-1D1C-4E1A-9EB7-774D1B64B25DQ30352761-125B5E4B-9898-4BB5-9D93-010D1DE69A90Q33235602-8697658E-BA92-426D-9BA3-8D3642A22670Q33647988-12154296-6F4C-4F6A-AA0D-1F9B14964709Q33719929-1EE6EFEB-B78A-454C-8229-C2AA5282E042Q33751536-36A00090-D012-4052-8347-35B8305B89B5Q33958775-C0CCEFBE-681D-4180-A2C2-7F26D07B0382Q34348367-2C96DC1E-67EF-4D12-95DA-27FF5300D14AQ34507329-CBE7FE86-0B75-4B4D-864A-EC7BF86BC36EQ34976677-28CFFB8C-C974-4773-820D-9DDB6949D421Q35102868-4E94B260-91B6-4071-AB08-88E5AD0C6E90Q35588059-8FAB01B0-CFEB-418B-A9A2-F82829B21454Q35791647-4FE8812C-0D8F-4940-AC74-69A1944DBBF0Q36063593-9C565455-6D97-44FB-B548-19D825046B93Q36999950-731C5B9F-5A35-4A12-B161-1CEF42B9FE99Q37235744-AAC2AA51-FEF0-4CB7-A72F-98CEBB51F820Q37261316-5154FE73-DD03-4CFB-A209-B0A6A47991F9Q37696422-D2FA32DD-0978-4161-BBBB-D1E199068CFDQ37756050-90F962FE-1617-4D41-9090-0FE648E92167Q38307071-1032D7B9-4F1E-4AE8-A308-F107EDFF7FFCQ38683309-50FF079B-F7AF-450F-97BD-CB0C16021571Q38746327-1D43EEE8-5AE9-4F03-9ADC-012DAB8BE0DDQ38847885-E17B4EA1-53AE-41C4-BD4F-1A6CDBA8A4F1Q39152592-B643E1E7-F287-4FED-9259-008E9952A909Q39465645-14F72A5B-DE53-492A-BE86-A356B93686EDQ40102979-CC2ACC5E-4623-4CFC-A3FB-1251B53A4684Q40816090-03055B7A-EB3A-41C4-AEE7-5D95E14A30E9Q40881078-F150A301-1A1F-429D-AE8A-A3D7BD730BADQ41026601-308169B2-7B41-492C-B5C1-C4871B80329DQ41087873-687D5622-95D7-4EDA-B07F-3EA769549D3EQ41662020-95A02B67-DF4C-4009-B9FB-E7C08B34DF9EQ41716157-B5C7F0C1-8E37-4D81-B47B-1B12AF9DEED1Q41835932-E8E7CC2F-E3C4-4C76-AB5F-2955888D72EEQ42478441-3A6F5ECE-7E02-4EDB-9162-39F96C88FA5DQ42688771-972A51DE-9B35-4DB9-A410-B42B1BAAE402Q42805429-290E6EA9-DDB9-49D1-8F34-79F94324CA62Q42812003-045B0C00-81C9-43EE-902E-8E2A5A8068CFQ42857330-4A1FEB66-121E-4367-A35A-F46810BA457AQ43024330-1E44D6C4-B0D3-4BF5-BDA9-4CFAC569ECC9Q43585460-3D762DB0-999D-4DF2-A16B-30068C734B1E
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Marco G Baroni
@nl
Marco G Baroni
@sl
Marco G. Baroni
@en
Marco G. Baroni
@es
type
label
Marco G Baroni
@nl
Marco G Baroni
@sl
Marco G. Baroni
@en
Marco G. Baroni
@es
prefLabel
Marco G Baroni
@nl
Marco G Baroni
@sl
Marco G. Baroni
@en
Marco G. Baroni
@es
P106
P1153
18533272500
P31
P496
0000-0002-3224-6078